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Abstract
Aims/hypothesis Our aim was to determine whether a range of prespecified retinal vessel traits were associated with incident
diabetic retinopathy in adults with type 2 diabetes.
Methods In the prospective observational cohort Edinburgh Type 2 Diabetes Study of 1066 adults with type 2 diabetes, aged 60–
75 years at recruitment, 718 were free from diabetic retinopathy at baseline. Baseline retinal traits including vessel widths, tortuosity
(curvature) and fractal dimensions (network complexity), were quantified using fundus camera images and semiautomated software,
and analysed using logistic regression for their association with incident diabetic retinopathy over 10 years.
Results The incidence of diabetic retinopathy was 11.4% (n = 82) over 10 years. After adjustment for a range of vascular and
diabetes-related risk factors, both increased venular tortuosity (OR 1.51; 95% CI 1.15, 1.98; p = 0.003) and decreased fractal
dimension (OR 0.75; 95% CI 0.58, 0.96; p = 0.025) were associated with incident retinopathy. There was no evidence of an
association with arterial tortuosity, and associations between measurements of vessel widths and retinopathy lost statistical
significance after adjustment for diabetes-related factors and vascular disease. Adding venular tortuosity to a model including
established risk factors for diabetic retinopathy (HbA1c, BP and kidney function) improved the discriminative ability (C statistic
increased from 0.624 to 0.640, p = 0.013), but no such benefit was found with fractal dimension.
Conclusions/interpretation Increased retinal venular tortuosity and decreased fractal dimension are associated with incident
diabetic retinopathy, independent of classical risk factors. There is some evidence that venular tortuosity may be a useful
biomarker to improve the predictive ability of models based on established retinopathy risk factors, and its inclusion in further
risk prediction modelling is warranted.
Keywords Diabetic retinopathy .Digital retinal imaging .Epidemiology .Logistic regression .Microvasculardisease .Prediction
modelling . Prospective cohort . Retinal vessel traits . Type 2 diabetes . Vascular complications
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Introduction
The microvasculature of the retina offers a unique opportunity
for research of the systemic vascular system as it is one of the
only locations in vivo where it is possible to visualise the
vasculature of the human body non-invasively [1]. Diabetic
retinopathy is one of the earliest microvascular complications
of diabetes and is highly prevalent, with a conservative esti-
mate in adults with diabetes of around 29%, and sight-
threatening retinopathy affecting 4.4% [2]. It is well known
that providing early treatment for diabetic retinopathy can
improve visual outcomes [3], such that screening programmes
are commonplace in many countries. However, these
programmes can only detect prevalent disease, so there is a
need for more sensitive screening for prepathological stages of
retinopathy as well as improved stratification to help clinicians
understand which patients are more likely to progress to sight-
threatening stages. One area that is receiving increasing atten-
tion is morphological analysis of the appearance of retinal
venules and arterioles [4–6].
Several cross-sectional studies have investigated associa-
tions between measurements of retinal vessel traits on fundus
camera images and diabetic retinopathy in older adults, and
these studies provided some evidence for an association
between abnormally wider retinal venular calibre and diabetic
retinopathy [7–9]. However, longitudinal evidence for other
quantifiable retinal traits, such as vessel tortuosity and fractal
dimension, reveal additional signs of vascular health and
disease is limited. Critically, there is a need for prospective
studies to evaluate if retinal vascular measurements could be
used as biomarkers to predict subsequent development of
diabetic retinopathy.
The objective of this analysis was to determine if retinal
vessel traits measured at baseline in an ongoing, prospective
study of older adults with type 2 diabetes were associated with
incident diabetic retinopathy during 10-year follow-up,
beyond other known risk factors for retinopathy.
Methods
Study design and participants The Edinburgh Type 2
Diabetes Study (ET2DS) is a longitudinal cohort of older
men and women based in Lothian, Scotland, designed to
investigate the role of risk factors for vascular complications
of type 2 diabetes. Methods have been previously reported in
detail including in Price et al (2008) [10]. In brief, recruitment
occurred in 2006–2007 when participants aged 60–75 years
were randomly selected within sex and 5-year age bands from
the Lothian Diabetes Register, with the final cohort shown to
be largely representative of the target population of all older
men and women with type 2 diabetes residing in Lothian [11].
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All people within the Lothian Diabetes Register have a diabe-
tes diagnosis according to WHO criteria, but in order to be
enrolled in the ET2DS participants had to meet certain criteria
to ensure a robust diagnosis of type 2 diabetes [12]. These
criteria included that participants had to be taking oral
glucose-lowering medications and/or insulin, or, if partici-
pants managed their diabetes through diet control methods
alone, had to have an HbA1c measure of >48 mmol/mol
(6.5%) at the baseline clinic. Further investigation of clinical
records was undertaken if there was concern of the diabetes
status of a potential participant.
Ethical permission was granted by the Lothian Medical
Research Ethics Committee at baseline and follow-up, and
all participants gave written informed consent at recruitment
and prior to subsequent clinic attendance. Data were collected
at designated research clinics as well as through linkage to
routine medical and death records, at baseline and during
follow-up.
Baseline data collection Baseline fasting blood samples were
used to measure total serum cholesterol, HDL-cholesterol and
HbA1c, and early morning urine samples tomeasure creatinine
and albumin. Height, weight, and systolic and diastolic brachi-
al blood BPs were measured using established standard oper-
ating procedures by trained researchers, and self-administered
questionnaires were used to collect data on diabetes history
and treatment, smoking habits, medications and comorbidi-
ties. For cardiovascular and cerebrovascular events, answers
from baseline questionnaires on medical history, the WHO
chest pain and Edinburgh Claudication questionnaires, and
results from a standard 12-lead ECG were combined with
routine hospital discharge data [11] to define macrovascular
disease (one or more of myocardial infarction, angina, stroke
or transient ischaemic attack).
To determine retinopathy status at baseline and obtain reti-
nal photographs to assess quantitative traits, all study partici-
pants were invited to an eye appointment within 3 weeks of
their original baseline clinic appointment [13]. Mydriasis was
achieved using 1% tropicamide drops and standard seven-
field non-stereoscopic retinal colour photographs were taken
of both eyes at 35° using a high-resolution TOPCON TRC-
50FX digital retinal camera (Topcon Optical Company,
Tokyo, Japan). The images were taken by a single, specially
trained medical photographer. Retinopathy grading was
undertaken by two trained optometrists, working indepen-
dently, using all seven fields of both eyes and a predefined
protocol using Early Treatment Diabetic Retinopathy Study
(ETDRS) criteria [14]. An ETDRS grade of ≥20 in any field of
either eye was considered as presence of diabetic retinopathy
at baseline.
Incident retinopathy To determine incident retinopathy,
results of retinopathy grading by the Scottish Diabetic
Retinopathy Screening Programme (Scottish DRS) were
requested, which operates an annual screening programme
for all people in Scotland with diabetes. We were able to
request all screening data through the 10-year follow-up peri-
od, which helped to reduce bias due to attrition. After pupil
dilation using 1% tropicamide, images were taken of both
eyes with a TOPCON NW8 fundus camera with Nikon
D700 digital backs at a 45–50° angle. Photography and grad-
ing were performed by specially trained and accredited medi-
cal photographers using a grading scheme that ranges fromR0
(no diabetic retinopathy) to R4 (proliferative diabetic retinop-
athy) [15]. Grade R1 is considered mild, R2 is observable, R3
is referable and R4 is proliferative. For this analysis, incident
retinopathy was considered any grade R1 or above during the
follow-up period. It is not uncommon for a person that has
received a grade of R1 to then revert to R0 at another grading
because of ar tefac ts in the imaging, heal ing of
microaneurysms without further progression of retinopathy
or other reasons. Because of this, if a participant received a
grade of R1 but no higher during the follow-up period, a grade
of R1 at a minimum of two consecutive screenings was
required for them to be considered to have incident retinopa-
thy. A participant was also determined to have incident reti-
nopathy if there were laser photocoagulation scars present (an
indication of prior treatment for diabetic retinopathy).
Retinal vessel trait measurements Retinal vessel traits were
measured at baseline by a single researcher (E. Sandoval
Garcia), trained specially by an expert senior researcher (T.
J. MacGillivray), using the Vascular Assessment and
Measurement Platform for Images of the Retina
(VAMPIRE) software (version 3.1.0, Universities of
Edinburgh and Dundee, UK) [16]. The right eye image was
analysed, unless unsuitable because of poor image quality
leading to hazy or obscured views of the retinal vasculature,
in which case the left eye image was used. Measures of inter-
and intragrader agreement were made with involvement of a
third, specially trained researcher (R. B. Forster).
Measurements were taken using the optic disc-centred field.
To analyse an image, the user uploads it to the software
upon which the boundary of the optic disc and the position of
the fovea are detected automatically. The user can adjust these
features if necessary (e.g. the optic disc in some patients may
be unclear because of pathology or the fovea may have been
masked by poor illumination at image acquisition). The soft-
ware then automatically generates a map of the retinal vascu-
lature and attempts to classify vessels as arterioles or venules,
which can be edited by the user if some vessels are labelled
incorrectly. A final measurement step is undertaken to gener-
ate quantitative traits.
The traits assessed for this analysis include vessel calibre, or
width, measured as summary indices (central retinal arterial
equivalent [CRAE] and central retinal venular equivalent
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[CRVE]), tortuosity, which describes the degree of curvature of
a vessel (i.e. how much the vessels twist and turn, arterial and
venular separately), and total fractal dimension, which
describes how the vascular pattern fills a two-dimensional
space and is thus a measure of complexity or sparsity of the
vascular network. For CRAE and CRVE, the software iden-
tifies the six widest arterioles and venules that cross a
standardised region called zone B [16]. Tortuosity is calculated
using the six widest arteriole and venule vessels crossing anoth-
er standardised region, zone C [17]. Fractal dimension was
measured by multifractal analysis using the generalised sand
box method, which generates an estimation of fractal dimen-
sion of several scales from zone C of a binary map [18, 19].
Statistical analysis All variables were checked for normality
and the following were transformed prior to analysis: duration
of diabetes, albumin/creatinine ratio (ACR), tortuosity and
fractal dimension. All of these except fractal dimension were
log transformed using the natural log. Fractal dimension,
which was only slightly skewed, was modified using rank
transformation. In addition, fractal dimension was
standardised for use in regression modelling because it is a
continuous, unitless measure that falls between 1 and 2, and
can be difficult to interpret in an unstandardised form. Values
were standardised using the mean and SD to produce a scaled
variable with a mean of 0 and SD of 1 (values maintain the
same relationship to one another as the unscaled variable). The
resultant OR can be interpreted as the odds given an increase
of one SD.
To evaluate reliability and agreement of the measured reti-
nal traits, interclass correlation coefficients (ICC) were used to
measure intra- and intergrader agreement. A two-way mixed
effects design was used to evaluate the mean of two graders or
twomeasurements for consistency [20]. For baselinemeasure-
ments, 3% (n = 30) of participants were used for the analysis
of inter- and intragrader reliability.
Variables of interest were initially evaluated usingWelch’s
unpaired two-sample t test for continuous variables, or
Wilcoxon test if assumptions were not met, and Pearson’s
χ2 test with Yate’s continuity correction for categorical
variables.
Logistic regression analyses were used to evaluate the rela-
tionship between retinal vessel traits and incident retinopathy,
and the model was built by adding blocks of covariates to
better understand the impact of the variables within the model.
First, an unadjusted model was generated, then age and sex
were controlled for, followed by cardiometabolic risk factors
(BMI, smoking status, systolic BP, and total cholesterol:HDL-
cholesterol ratio), then the addition of diabetic risk factors
(HbA1c, duration of diabetes and diabetic treatment type)
and finally vascular disease risk factors were added (a
composite history of macrovascular disease as well as
ACR). When measuring vessel width, arterial and venular
vessels were evaluated separately, as CRAE or CRVE, but
the corresponding value for the opposite measure was added
as a covariate in the final model because of the large amount of
shared variance. If there was no evidence of an association at
the unadjusted or age- and sex-adjusted stages, the analysis
was halted to avoid the risk of findings through multiple test-
ing. Only cases with no missing data were included in logistic
regression, and we planned to investigate any covariates with
missing data exceeding 3.5% of total cases.
Subgroup analysis was planned to evaluate the different
severities of retinopathy gradings. Grading groups would
include mild retinopathy (R1), moderate (R2 and R3) and
proliferative retinopathy (R4). However, the very small number
of incident retinopathy cases between R2 and R4 meant that
such analysis was not undertaken. Ethnicity subgroupswere not
evaluated as the ET2DS consists of 98% white British partici-
pants, reflecting the general population at baseline.
Initially, a Cox proportional hazards regression model was
considered, but the proportional hazards assumption was
violated and could not be resolved, so logistic regression
was the preferred approach.
If any vessel traits were found to be independently associ-
ated with incident retinopathy they would be evaluated, in
combination with the most highly predictive risk factors
(HbA1c, systolic BP and ACR) [2, 21–24], using Harrell’s
concordance statistic or C statistic to see if the model was
improved, which is used to evaluate the discriminative ability
of the model. The models would also be evaluated using the
likelihood ratio test and Akaike’s information criterion (AIC).
A small subset of the total ET2DS population was evaluated
for changes in retinal vessel traits, measuring retinal traits at
baseline and then at the latest follow-up image available, suit-
able for analysis, using retinal images from the Scottish DRS.
To test for a difference in the retinal trait from baseline to
follow-up, Welch’s two-sample paired t test for continuous
variables was used, or a Wilcoxon test if assumptions were
not met.
All final models were evaluated for concerns with
multicollinearity and linearity. Goodness of fit was evaluated
using the Hosmer–Lemeshow test, residuals were inspected
for outliers and influential cases, and interaction with predictor
variables was investigated.
A two-sided p value ≤0.05 was used to indicate evidence of
statistical significance. Logistic regression results were
presented as OR and 95% CI, and all statistical analyses were
performed using R version 3.5.1 [25].
Results
At baseline, 340 of 1066 participants had prevalent diabetic
retinopathy and eight did not have sufficient data to determine
their retinopathy status (they did not attend the baseline
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ET2DS eye screening and did not attend a Scottish DRS
screening around the time of ET2DS baseline). During
10 years of follow-up, 82 participants (11.4%) of 718 with
no baseline prevalent disease developed retinopathy (Fig. 1).
The median number of screening visits was 8 with a range of 1
to 12. The vast majority had mild disease with 77 graded R1,
one R2 and two R3 as well as two participants who had R4
graded disease.
Overall, participants with incident retinopathy were similar
to those without for the key baseline variables reported in
Table 1. However, those that developed retinopathy had
increased HbA1c (60 mmol/mol vs 55 mmol/mol (7.6% vs
7.2%)). Both vessel width measures, CRAE and CRVE, and
fractal dimension were reduced in those with incident retinop-
athy, while venular tortuosity was increased.
Repeatability for retinal traits between graders was good,
with ICC values between 0.81 (95% CI 0.61, 0.91) for fractal
dimension to 0.91 (95% CI 0.81, 0.96) for arterial tortuosity.
Intra-grader ICC values were also very good, ranging from
0.95 (95% CI 0.90, 0.98) for CRVE to 0.98 (95% CI 0.96,
0.99) for CRAE.
Association between retinal vessel traits and diabetic
retinopathy.
Results of logistic regression assessing the association
between the retinal vessel traits and diabetic retinopathy are
shown in Table 2.
CRAE In the unadjustedmodel, decreased CRAE (i.e. narrower
arterioles) was associated with incident retinopathy (OR 0.93;
95% CI 0.87, 0.99; p = 0.028). This relationship was main-
tained after multivariable adjustment for age and sex, as well
as after adding cardiometabolic and diabetes-related risk
factors, with little change in the point estimate at each step.
However, the relationship lost statistical significance after
vascular disease history and CRVE were incorporated (OR
0.95; 95% CI 0.87, 1.03; p = 0.212).
CRVE In unadjusted and multivariable-adjusted models,
evidence for an association between decreased CRVE (i.e.
narrower venules) and incident retinopathy was weak (unad-
justedOR 0.95; 95%CI 0.91, 1.00; p = 0.058; OR after adjust-
ment for age, sex, cardiometabolic risk factors 0.95; 95% CI
0.91, 1.00; p = 0.048). The association was not evident after
further adjustment for diabetes-related risk factors, vascular
risk factors and arterial width.
Arterial and venular tortuosity Arterial tortuosity was not
associated with incident retinopathy (unadjusted OR 0.99;
95% CI 0.81, 1.22; p = 0.946). There was evidence of a rela-
tively strong association between increased venular tortuosity
(i.e. more twisted venules) and incident retinopathy, OR 1.43
(95% CI 1.11, 1.84; p = 0.005) and this was maintained after
each block of covariates was added (full multivariable-
adjusted OR 1.51; 95% CI 1.15, 1.98; p = 0.003).
Fractal dimension Despite little evidence of an association
between decreased fractal dimension (i.e. a sparser vascular
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Fig. 1 Diabetic retinopathy in the ET2DS population at baseline and year 10
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(unadjusted OR 0.80; 95% CI 0.63, 1.01; p = 0.059; age and
sex-adjusted OR 0.79; 95% CI 0.62, 1.00; p = 0.050),
evidence of an association was evident after adjustment for
cardiometabolic and diabetes risk factors (OR 0.76; CI 0.60,
0.98; p = 0.033) and in full multivariable analysis (OR 0.75;
95% CI 0.58, 0.96; p = 0.017).
Predictionmodelling for venular tortuosity and fractal dimen-
sion Venular tortuosity and fractal dimension were added,
separately, to a model that contained the most highly cited
risk factors for diabetic retinopathy (HbA1c, ACR and systolic
BP). For venular tortuosity the discriminative ability of the
resultant model improved from 0.624 to 0.640, based on the
Table 1 Baseline characteristics







Age, years 718 67.4 (4.1) 67.9 (4.2) 0.222
Sex, men 718 40 (48.2%) 300 (48.7%) 0.920
Ever smoker, yes 718 40 (48.2%) 335 (54.4%) 0.337
BMI, kg/m2 718 31.0 (5.9) 31.5 (5.6) 0.720
Systolic BP, mmHg 716 134.7 (14.8) 132.9 (15.9) 0.286
Total cholesterol:HDL-cholesterol ratio 714 3.6 (1.2) 3.5 (1.1) 0.564
HbA1c 712 0.006
mmol/mol 60 (10.9) 55 (10.9)
% 7.6 (1.0) 7.2 (1.0)
Duration of diabetes, years, median (IQR) 712 5.0 (3.0–9.0) 5.0 (3.0–9.0) 0.515
Diabetes treatment 717 0.186
Diet controlled (%) 13 (15.7%) 152 (24.7%)
Tablets (%) 60 (72.3%) 399 (64.8%)
Insulin (%) 10 (12.0%) 63 (10.2%)
Macrovascular events, yes 718 25 (30.1%) 206 (33.4%) 0.625
ACR, mg/mmol, median (IQR) 713 1.2 (0.9–2.1) 1.1 (0.7–1.7) 0.054
CRAE, pixels 694 32.03 (3.71) 33.03 (3.78) 0.018
CRVE, pixels 694 43.54 (4.36) 44.53 (5.04) 0.044
Arterial tortuosity 694 −10.11 (1.26) −10.11 (1.11) 0.914
Venular tortuosity 694 −9.71 (1.06) −10.01 (0.87) 0.016
Fractal dimension 686 1.74 (0.08) 1.75 (0.07) 0.048
Values are mean (SD) or n (%) unless otherwise stated
Table 2 Association between retinal vessel traits and incident retinopathy: logistic regression
CRAE CRVE Arterial tortuosity Venular tortuosity Fractal dimension
Model OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
1a 0.93 (0.87, 0.99) 0.028 0.95 (0.91, 1.00) 0.058 0.99 (0.81, 1.22) 0.946 1.43 (1.11, 1.84) 0.005 0.80 (0.63, 1.01) 0.059
2b 0.93 (0.87, 0.99) 0.023 0.95 (0.91, 1.00) 0.047 0.99 (0.80, 1.22) 0.923 1.44 (1.12, 1.86) 0.004 0.79 (0.62, 1.00) 0.050
3c 0.93 (0.87, 0.99) 0.030 0.95 (0.91, 1.00) 0.048 1.49 (1.16, 1.93) 0.002 0.80 (0.63, 1.02) 0.073
4d 0.93 (0.87, 1.00) 0.038 0.95 (0.91, 1.00) 0.051 1.57 (1.21, 2.04) 0.001 0.76 (0.60, 0.98) 0.033
5e 0.95 (0.87, 1.03) 0.212 1.00 (0.58, 1.75) 0.999 1.51 (1.15, 1.98) 0.003 0.75 (0.58, 0.96) 0.025
aModel 1: unadjusted
bModel 2: age- and sex-adjusted
cModel 3: Model 2 + cardiometabolic risk factors (BMI, smoking status, systolic BP and total cholesterol:HDL-cholesterol ratio)
dModel 4: Model 3 + diabetes-related risk factors (HbA1c, duration of diabetes and diabetic treatment type)
eModel 5:Model 4 + vascular disease (composite CVD andACR) + CRAE or CRVEwhen analysing CRAE or CRVE; CRAE and CRVE n=655 (n=63
removed because of missing data), tortuosity n=659 (n=59 observations removed because of missing data) and fractal dimension n=641 (n=77
observations removed because of missing data)
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C statistic, and was confirmed by the Likelihood ratio test, p =
0.013 and AIC measure, which decreased from 487.65 to
483.43, showing a statistically significant improvement in
the model. However, when fractal dimension was added, the
C statistic decreased from 0.625 to 0.621 (p value 0.048 for
likelihood ratio test), indicating the addition did not improve
the model. Values are shown in Table 3.
Model fit was evaluated by comparing the C statistic and
AIC between the unadjusted model and the fully adjusted
model and the Hosmer–Lemeshow goodness of fit test was
used to look for evidence of poor model fit. All models
demonstrated good fit, and when evaluating residuals there
was no evidence of strong outliers or influential cases, and
no indication of interaction.
Change in retinal traits over time In a subset of the cohort, n =
170, we evaluated if there was evidence of change in the
individual retinal traits over time using two timepoints: base-
line and closest to the 10-year follow-up time point. We iden-
tified no differences in width or tortuosity, but a statistically
significant decrease in fractal dimension. This subset was not
powered to evaluate those with incident diabetic retinopathy,
but of the 19 cases that were included in this subset, they
followed the same pattern: a decrease in fractal dimension
but no difference in widths or tortuosity.
Discussion
Increased venular tortuosity and decreased fractal dimension
were independently associated with incident diabetic retinop-
athy above and beyond other known risk factors. There was
also an association between narrower vessel widths with
diabetic retinopathy, but the associations were no longer
evident when all covariates were added to the model. In
exploratory analyses, venular tortuosity was shown to
improve upon the discriminative ability of a model that
included the most cited risk factors for retinopathy, suggesting
a promising biomarker for future in-depth prediction
modelling.
There are several strengths in our analysis. The ET2DS is a
well-established, representative cohort with a large amount of
information on participants at baseline, which increases the
generalisability of the findings, enabling multivariable adjust-
ment and long-term follow-up for incident retinopathy.
During data collection, systematic and random error were
reduced through the use of standard operating procedures, as
well as linkage to routine data from high-quality sources,
including diabetic retinopathy screening [26, 27].
Semiautomatic retinal vessel assessment using VAMPIRE
software allowed for reduction in random error and produced
reliable measurements efficiently.
There were also some unavoidable limitations and findings
that must be treated with caution. In the model used to test the
addition of venular tortuosity and fractal dimension for
improvement in discrimination, the C statistic did not meet
the general convention of a ‘good model’ (cut-off 0.70) and
the ET2DS was not large enough to appropriately develop a
full prediction model. Notably, amongst previous studies
considering the development of a prediction tool for diabetic
retinopathy, none have been reliably replicated and imple-
mented in clinical practice [28]. Our findings suggest that
future work in this area should consider inclusion of ‘novel’
retinal traits, especially venular tortuosity.
Our study was further limited by insufficient power to
allow subgroup analysis by retinopathy severity grading (only
two cases of incident R3- and two cases of incident R4-graded
retinopathy). For replication of these findings, it would be
ideal to conduct this analysis in a cohort with newly diagnosed
diabetes, in order to capture more cases of incident severe
retinopathy during follow-up, as there is evidence that those
that develop clinically meaningful diabetic retinopathy are
more likely to have a retinopathy diagnosis earlier [29].
As the number of studies reporting on retinal vessel traits
increases, there is increasing concern about direct comparison
between different measurement platforms being used because
of heterogeneity in algorithms and methods. A recent study
carried out a direct comparison of a wide number of vessel
measurements between VAMPIRE and Singapore ‘I’ Vessel
Assessment (SIVA; National University of Singapore,
Singapore) and found poor agreement between the software
platforms [19]. Another study, which compared results for
CRAE and CRVE between SIVA, Interactive Vessel
Analysis (University of Wisconsin–Madison, WI) and retinal
analysis (Department of Ophthalmology and Visual Science,
University of Wisconsin–Madison), also found poor
Table 3 Discriminative changes in model with addition of tortuosity and fractal dimension
Change Venular tortuosity Fractal dimension
C statistic AIC Likelihood ratio
test p value
C statistic AIC Likelihood
ratio test p value
Base model 0.624 487.65 0.013 0.625 485.22 0.048
Base model + retinal trait 0.640 483.43 0.621 483.32
Base model is made up of HbA1c, systolic BP and ACR
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agreement, but associations with systemic factors including
age, BP and cholesterol were similar between applications
[30]. Yip et al suggested that use of a conversion algorithm
between the platforms could help overcome differences.
There is a current debate around retinal vessel widths
changing during different phases of the cardiac cycle that
should be considered when interpreting the results of this type
of study [31]. However, a study evaluating observer bias did
not find a difference when using ECG-synced vs non-synced
images [32]. Also, it is debatable whether the software pack-
ages are sensitive enough to pick up such slight changes in
width as the resolution of a fundus camera is roughly 7 μm
and pulsatile changes are likely to be less than 1μm in size [1].
There have been similar studies to ours that have evaluated
the relationship between venular tortuosity and diabetic reti-
nopathy. In one longitudinal analysis of the Wisconsin
Epidemiological Study of Diabetic Retinopathy (WESDR)
with 1370 people with type 2 diabetes, increased venular
tortuosity was associated with incident proliferative diabetic
retinopathy, but not any incident retinopathy [33]. Several
other studies did not find any statistically significant associa-
tions but interestingly, for all these studies, their direction of
effect was consistent with the findings of the ET2DS analysis
[6, 34, 35]. It should be noted that these studies were either in
younger type 1 diabetes populations or hadmixed aetiology of
diabetes, and in some cases analysis methods were quite
different.
Two observational studies, in younger people with type 1
diabetes, also found an association with lower fractal dimen-
sion and proliferative diabetic retinopathy; one study was
cross-sectional [5] and the other longitudinal [4]. There have
been other similar longitudinal studies that found no evidence
of an association [33], and one study found an association
between higher arteriolar fractal dimension and diabetic reti-
nopathy [35]. Using different analysis and computational
methods, two recent studies showed the ability of fractal
dimension to assist in identification of very early retinal
disease [36, 37]. Both studies were conducted in people with
retinopathy, so prediction was not the aim. However, these
studies provide evidence that could help determine how the
retinal vasculature is changing in the very early stages of
disease.
Two recent studies have provided evidence on using retinal
vessel traits in predictionmodelling for retinopathy. Both used
principle components analysis to combine multiple measures
and extract a single component. One study found an improve-
ment in the discriminative ability of modelling for diabetic
retinopathy [35], agreeing with the findings from this analysis,
while the other analysis found no change [33]. This also
touches on the progression in the field of using reductive
statistical methods to combine information from multiple reti-
nal traits, which should be considered in future analyses and
has been done for other disease outcomes.
Measurement in change in the retinal traits over time is a
novel approach and the data presented in this paper represent
the longest follow-up, mean of 9 years, in people with type 2
diabetes, although our study was not well powered to evaluate
the association with diabetic retinopathy. One other study,
from the WESDR population, evaluated changes over 6 years
and found a narrowing of arterioles and widening of venules,
but reported no changes in fractal dimension [9].
There is currently no exact mechanistic explanation for the
changes seen in retinal vessels prior to pathology and they
would most likely differ for different vessel traits, but haemo-
dynamic changes, especially in more thinly walled venular
vessels, are probably key. Previous studies have shown that
changes in brachial BP from exercise can lead to incremental
changes in retinal pressure as a normal process of autoregula-
tion, but these processes may break down in older people and
those with diabetes [38, 39]. It is therefore possible that with
sustained blood flow changes not only from chronically
increased BP, but also age and damage caused by
hyperglycaemia, the smaller vessels in the retina undergo
cumulative alterations. There is also a possible genetic under-
pinning as recent data from the Genetics of Diabetes Audit
and Research Tayside and Scotland (GoDARTS) study has
shown a genetic link with differences in venular tortuosity that
is also associated with risk factors for coronary artery disease
[40].
Fractal dimension in relation to diabetic retinopathy is
complex, because throughout the course of the disease there
are cumulative vascular changes that may create opposing
findings in fractal dimension. Fractal dimension may change
dramatically from moderate non-proliferative disease to
proliferative retinopathy, characterised by new vessel growth,
and may be part of the reason some studies find increased
fractal dimension to be associated with diabetic retinopathy
[41, 42]. Unfortunately, in this analysis there were not enough
people with proliferative retinopathy to undertake robust
analysis.
In conclusion, there is gathering evidence from this analy-
sis and other similar studies that retinal vessel traits have the
potential to assist in the prediction of vascular outcomes such
as diabetic retinopathy. Not only could earlier identification of
retinopathy help individuals maintain healthy vision for
longer, but there is also currently a debate around optimal
frequency of retinopathy screening. Findings such as ours
could assist screening programmes in determining who is
most at risk of developing sight-threatening retinopathy in
order to inform stratified screening intervals [26]. Such adjust-
ments could help reduce burden on the healthcare services and
prioritise people with the most need. Although our findings
are suggestive of a possible benefit from incorporating venular
tortuosity measures into a risk prediction tool, further research
is needed to create a robust prediction tool that can be used
effectively in clinical practice. In addition to validating the
Diabetologia
results of this research, future research should focus on over-
coming the heterogeneity between findings from different
software types, evaluating change in the retinal traits over time
as well as developing cut points within venular tortuosity to
help clinicians indicate increased risk of diabetic retinopathy.
Acknowledgements As a study team, we would like to extend our
deepest gratitude to the participants of ET2DS, as well as the staff at
the Edinburgh Clinical Research Facility.
Thank you to the Scottish DRS Collaborative, including Norah Grant,
Mike Black and Neville Lee for their assistance in linking to the retinop-
athy screening data. We would like to thank the input and appraisal from
Professors Alex Doney (University of Dundee) and Niall Anderson
(University of Edinburgh).
Data availability Because of the sensitive nature of the clinical data
the full dataset is not publicly available, but the protocol and statistical
analysis plan are available by request to the corresponding author.
Funding The ET2DS was funded by a grant from the UK Medical
Research Council (Project Grant G0500877) and the Chief Scientist
Office of Scotland (Programme Support Grand CZQ/1/38). Diabetes
UK provided support in the form of a PhD studentship to the first author.
The funding bodies were not involved in the design of the study, data
collection and analysis, or interpretation of the results, and have not
imposed any restrictions on the publication of any findings.
Authors’ relationships and activities The authors declare that there are
no relationships or activities that might bias, or be perceived to bias, their
work.
Contribution statement RBF conducted the research and primary analy-
sis and drafted the manuscript, managed the revisions and approved the
final version for publication; ESG provided analysis of the baseline retinal
vessel traits and contributed to editing the manuscript and provided input
for revision and approval for the final publication version; AJS and SMG
provided primary data collections for the ET2DS and contributed to
editing and revising the manuscript and provided approval for the final
publication version; SM supported the data collection and data manage-
ment and contributed to editing the manuscript and has given final
approval for publication; TJM provided training for VAMIPRE software,
was integral in study design and development, and contributed to editing
and revising the manuscript and has given final approval for publication;
MWJS contributed to the study design of this analysis and is a leading
investigator for the ET2DS, provided support during primary data collec-
tion, contributed to editing the manuscript and has provided approval of
the final version for publication; JFP is the primary investigator of the
ET2DS and was a key influence on the design and development of this
analysis, contributed to editing and revising the manuscript and has
provided approval of the final version; RBF is the guarantor of this work.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adap-
tation, distribution and reproduction in any medium or format, as long as
you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in
the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
References
1. MacGillivray T, Trucco E, Cameron J, Dhillon B, Houston J, van
Beek E (2014) Retinal imaging as a source of biomarkers for diag-
nosis, characterization and prognosis of chronic illness or long-term
conditions. Br J Radiol 87(1040):20130832. https://doi.org/10.
1259/bjr.20130832
2. Zhang X, Saadine JB, Chou C et al (2010) Prevalence of Diabetic
Retinopathy in the United States, 2005-2008. JAMA 304(6):649–
656. https://doi.org/10.1001/jama.2010.1111
3. Early Treatment Diabetic Retinopathy Study Research Group
(1991) Early photocoagulation for diabetic retinopathy: ETDRS
report number 9. Ophthalmology 98(5):766–785. https://doi.org/
10.1016/S0161-6420(13)38011-7
4. Broe R, Rasmussen M, Frydkjaer-Olsen U et al (2014) Retinal
vessel calibers predict long-term microvascular complications in
type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987
(DCPD1987). Diabetes 63:3906–3914. https://doi.org/10.2337/
db14-0227
5. Grauslund J, Green A, Kawasaki R, Hodgson L, Sjolie AK (2010)
Retinal vascular fractals and microvascular and macrovascular
complications in type 1 diabetes. Ophthalmology 117(7):1400–
1405. https://doi.org/10.1016/j.ophtha.2009.10.047
6. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE
(2011) Retinal vascular tortuosity in persons with diabetes and
diabetic retinopathy. Diabetologia 54(9):2409–2416. https://doi.
org/10.1007/s00125-011-2200-y
7. Kifley A, Wang JJ, Cugati S, Wong TY (2007) Retinal Vascular
Caliber, Diabetes, and Retinopathy. Am J Ophthalmol 143(6):
1024–1026. https://doi.org/10.1016/j.ajo.2007.01.034
8. Nguyen TT, Wang JJ, Sharrett AR et al (2008) Relationship of
retinal vascular caliber with diabetes and retinopathy: the Multi-
Ethnic Study of Atherosclerosis (MESA). Diabetes Care 31(3):
544–549. https://doi.org/10.2337/dc07-1528
9. Klein R, Myers CE, Lee KE, Gangnon R (2012) Changes in retinal
vessel diameter and incidence and progression of diabetic retinop-
athy. Arch Ophthalmol 130(6):749–755. https://doi.org/10.1001/
archophthalmol.2011.2560
10. Price J, Reynolds R, Mitchell R et al (2008) The Edinburgh Type 2
Diabetes Study: study protocol. BMC Endocr Disord 8:18–28.
https://doi.org/10.1186/1472-6823-8-18
11. Marioni RE, StrachanMWJ, Reynolds RM et al (2010) Association
between raised inflammatory markers and cognitive decline in
elderly people with type 2 diabetes. Diabetes 59(3):710–713.
https://doi.org/10.2337/db09-1163
12. World Health Organization (2006) Definition and diagnosis of




13. Ding J, StrachanMWJ, Reynolds RM et al (2010) Diabetic retinop-
athy and cognitive decline in older people with type 2 diabetes: the
Edinburgh Type 2 Diabetes Study. Diabetes 59:2883–2889. https://
doi.org/10.2337/db10-0752
14. Early Treatment Diabetic Retinopathy Study Research Group
(1991) Grading diabetic retinopathy from stereoscopic color fundus
photographs — an extension of the Modified Airlie House
Classification. Ophthalmology 98(5):786–806. https://doi.org/10.
1016/S0161-6420(13)38012-9
15. Scottish Diabetic Retinopathy Screening Collaborative (2007)
Scottish Diabetic Retinopathy Grading Scheme 2007 v1.1. http://
Diabetologia
www.ndrs-wp.scot.nhs.uk/wp-content/uploads/2013/04/Grading-
Scheme-2007-v1.1.pdf. Accessed 8 Oct 2019
16. Knudtson M, Lee K, Hubbard L, Wong T, Klein R, Klein B (2003)
Revised formulas for summarizing retinal vessel diameters. Curr
Eye Res 27(3):143–149. https://doi.org/10.1076/ceyr.27.3.143.
16049
17. Lisowska A, Annunziata R, Loh G, Karl D, Trucco E (2014) An
experimental assessment of five indices of retinal vessel tortuosity
with the RET-TORT public dataset. Annu Int Conf IEEE Eng Med
Biol Soc 2014:5414–5417. https://doi.org/10.1109/EMBC.2014.
6944850
18. Stosic T, Stosic B (2006) Multifractal analysis of human retinal
vessels. IEEE Trans Med Imaging 25(8):1101–1107. https://doi.
org/10.1109/TMI.2006.879316
19. McGrory S, Taylor AM, Pellegrini E et al (2018) Towards stan-
dardization of quantitative retinal vascular parameters: comparison
of SIVA andVAMPIREMeasurements in the Lothian Birth Cohort
1936. Transl Vis Sci Technol 7(2):12. https://doi.org/10.1167/tvst.
7.2.12
20. Koo TK, Li MY (2016) A guideline of selecting and reporting
intraclass correlation coefficients for reliability research. J Chiropr
Med 15(2):155–163. https://doi.org/10.1016/j.jcm.2016.02.012
21. Bertelsen G, Peto T, Lindekleiv H et al (2013) Tromsø eye study:
prevalence and risk factors of diabetic retinopathy. Acta
Ophthalmol 91:716–721. https://doi.org/10.1111/j.1755-3768.
2012.2542.x
22. Liu Y, Yang J, Tao L et al (2017) Risk factors of diabetic retinop-
athy and sight-threatening diabetic retinopathy : a cross-sectional
study of 13 473 patients with type 2 diabetes mellitus in mainland
China. BMJ Open 7:e016280. https://doi.org/10.1136/bmjopen-
2017-016280
23. Salinero-Fort M, San Andres-Rebollo F, de Burgos-Lunar C,
Arrieta-Blanco F, Gomez-Campelo P (2013) Four-year incidence
of diabetic retinopathy in a Spanish cohort: the MADIABETES
study. PLoS One 8(10):e76417. https://doi.org/10.1371/journal.
pone.0076417
24. Stratton I, Kohner E, Aldington S et al (2001) UKPDS 50 : risk
factors for incidence and progression of retinopathy in Type II
diabetes over 6 years from diagnosis. Diabetologia 44:156–163.
https://doi.org/10.1007/s001250051594
25. R Core Team (2018) R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna,
Austria. version 3.5.1
26. Looker HC, Nyangoma SO et al (2014) Rates of referable eye
disease in the Scottish National Diabetic Retinopathy Screening
Programme. Br J Ophthalmol 98(6):790–795. https://doi.org/10.
1136/bjophthalmol-2013-303948
27. Ireland J (2017) Information Services Division (ISD): Overview of
Data Quality of Sources and Outputs. https://www.isdscotland.org/
About-ISD/About-Our-Statistics/. Accessed 7 Oct 2019
28. Stratton I, Aldington S, Cragg R et al (2014) Validation of model to
estimate risk of progression of diabetic retinopathy using screening
and clinical data in 3 cohorts. Diabetologia 57(Suppl1):S27. https://
doi.org/10.1007/s00125-014-3355-0
29. Jones C, Greenwood RH, Misra A, Bachmann M (2012) Incidence
and progression of diabetic population-based screening program in
England. Diabetes Care 35:592–596. https://doi.org/10.2337/dc11-
0943
30. Yip W, Tham YC, Hsu W et al (2016) Comparison of common
retinal vessel caliber measurement software and a conversion algo-
rithm. Transl Vis Sci Technol 5(5):11. https://doi.org/10.1167/tvst.
5.5.11
31. Chen HC, Patel V, Wiek J, Rassam SM, Kohner EM (1994) Vessel
diameter changes during the cardiac cycle. Eye 8:97–103. https://
doi.org/10.1038/eye.1994.19
32. Wei FF, Zhang ZY, Petit T et al (2016) Retinal microvascular
diameter, a hypertension-related trait, in ECG-gated vs. non-gated
images analyzed by IVAN and SIVA. Hypertens Res 39(12):886–
892. https://doi.org/10.1038/hr.2016.81
33. Klein R, Lee K, Danforth L et al (2018) The relationship of retinal
vessel geometric characteristics to the incidence and progression of
diabetic retinopathy. Ophthalmology 125:1784–1792. https://doi.
org/10.1016/j.ophtha.2018.04.023
34. Rasmussen ML, Broe R, Frydkjaer-Olsen U et al (2017) Retinal
vascular geometry and its association to microvascular complica-
tions in patients with type 1 diabetes: the Danish Cohort of Pediatric
Diabetes 1987 (DCPD1987). Graefes Arch Clin Exp Ophthalmol
255(2):293–299. https://doi.org/10.1007/s00417-016-3454-3
35. Cheung C, Sabanayagam C, LawAKP et al (2017) Retinal vascular
geometry and 6 year incidence and progression of diabetic retinop-
athy. Diabetologia 60(9):1770–1781. https://doi.org/10.1007/
s00125-017-4333-0
36. Amil P, Reyes-Manzano CF, Guzmán-Vargas L, Sendiña-Nadal I,
Masoller C (2019) Network-based features for retinal fundus vessel
structure analysis. PLoS One 14(7):1–15. https://doi.org/10.1371/
journal.pone.0220132
37. Colomer A, Naranjo V, Janvier T, Mossi JM (2018) Evaluation of
fractal dimension effectiveness for damage detection in retinal
background. J Comput Appl Math 337:341–353. https://doi.org/
10.1016/j.cam.2018.01.005
38. Jeppesen P, Gregersen PA, Bek T (2004) The age-dependent
decrease in the myogenic response of retinal arterioles as studied
with the Retinal Vessel Analyzer. Graefes Arch Clin Exp
Ophthalmol 242:914–919. https://doi.org/10.1007/s00417-004-
0945-4
39. Palkovits S, Fuchsjäger-Mayrl G, Kautzky-Willer A et al (2013)
Retinal white blood cell flux and systemic blood pressure in patients
with type 1 diabetes. Graefes Arch Clin Exp Ophthalmol 251(6):
1475–1481. https://doi.org/10.1007/s00417-012-2193-3
40. VeluchamyA, Ballerini L, Vitart V et al (2019) Novel genetic locus
influencing retinal venular tortuosity is also associated with risk of
coronary artery disease. Arterioscler Thromb Vasc Biol 39(12):
2542–2552. https://doi.org/10.1161/ATVBAHA.119.312552
41. Ting DSW, Tan GSW, Agrawal R et al (2017) Optical coherence
tomographic angiography in type 2 diabetes and diabetic retinopa-
thy. JAMA Ophthalmol 135(4):306–312. https://doi.org/10.1001/
jamaophthalmol.2016.5877
42. Cheung N, Donaghue KC, Liew G et al (2009) Quantitative assess-
ment of early diabetic retinopathy using fractal analysis. Diabetes
Care 32(1):106–110. https://doi.org/10.2337/dc08-1233
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Diabetologia
